PBI17 BUDGET IMPACT ANALYSIS OF INTRAVENOUS BIOSIMILAR RITUXIMAB AND TRASTUZUMAB COMPARED TO INTRAVENOUS AND SUBCUTANEOUS ORIGINATORS IN FRANCE, GERMANY, ITALY, SPAIN, AND THE UK

Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.121
https://www.valueinhealthjournal.com/article/S1098-3015(19)32499-4/fulltext
Section Title :
Section Order : 10079
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32499-4&doi=10.1016/j.jval.2019.09.121
HEOR Topics :
Tags :
Regions :